These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 12222700

  • 1. Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty.
    Kayikçioğlu M, Can L, Kültürsay H, Payzin S, Turkoğlu C.
    Acta Cardiol; 2002 Aug; 57(4):295-302. PubMed ID: 12222700
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, Schultheiss HP.
    Am J Cardiol; 2000 Dec 15; 86(12):1293-8. PubMed ID: 11113401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
    Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, Letterer R, Limacher M, Moye LA, Rouleau JL, Pfeffer MA, Braunwald E.
    J Am Coll Cardiol; 1998 Jul 15; 32(1):140-6. PubMed ID: 9669262
    [Abstract] [Full Text] [Related]

  • 8. [Comparison on long-term effects of atorvastatin or pravastatin combined with clopidogrel for patients undergoing coronary stenting: a randomized controlled trial].
    Han YL, Zhang ZL, Li Y, Wang SL, Jing QM, Wang ZL, Wang DM.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 25; 89(32):2240-4. PubMed ID: 20095333
    [Abstract] [Full Text] [Related]

  • 9. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
    Tonkin AM, Colquhoun D, Emberson J, Hague W, Keech A, Lane G, MacMahon S, Shaw J, Simes RJ, Thompson PL, White HD, Hunt D.
    Lancet; 2000 Dec 02; 356(9245):1871-5. PubMed ID: 11130382
    [Abstract] [Full Text] [Related]

  • 10. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC.
    N Engl J Med; 1999 Dec 23; 341(26):1949-56. PubMed ID: 10607811
    [Abstract] [Full Text] [Related]

  • 11. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
    Wong A, Mak KH, Chan C, Koh TH, Lau KW, Lim TT, Lim ST, Wong P, Sim LL, Lim YT, Tan HC, Lim YL.
    Catheter Cardiovasc Interv; 2004 Aug 23; 62(4):445-52. PubMed ID: 15274152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiographic and clinical outcome after percutaneous coronary interventions following combined fibrinolytic therapy in acute myocardial infarction.
    Dudek D, Dziewierz A, Rakowski T, Siudak Z, Wizimirski M, Legutko J, Batruś S, Mielecki W, Rzeszutko L, Zmudka K, Dubiel JS.
    Kardiol Pol; 2006 Mar 23; 64(3):239-47; discussion 248-9. PubMed ID: 16583321
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.